Body Weight
Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors
About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.
Tirzepatide lowers body weight for adults with obesity, regardless of disease duration
Adults with obesity for 20 years or more who received tirzepatide had a similar reduction in body weight and waist circumference as adults with shorter obesity duration, according to a post hoc analysis of four SURMOUNT trials.
Children with atopic dermatitis may experience growth hinderance
SAN DIEGO — Researchers found that children with moderate to severe atopic dermatitis have a higher mean weight and BMI, but a lower mean height, than healthy children, according to a poster presented here.
Excess weight may be key driver of early-onset colorectal cancer
Excess body weight may be a key risk factor for the development of early-onset colorectal cancer, according to research published in International Journal of Cancer.
Scale using biosensor technology detects HF events more often than standard of care
A congestion index derived from a scale using biosensor technology better predicted heart failure events compared with standard weight-based monitoring, researchers reported at the Technology and Heart Failure Therapeutics annual meeting.
Tirzepatide cuts HbA1c, body weight for adults with type 1 diabetes in real-world study
Adults with type 1 diabetes who received tirzepatide in a real-world setting had reductions in HbA1c and body weight at 3 months that were sustained for up to 8 months, according to study data.
Combination insulin icodec and semaglutide cuts HbA1c and body weight in type 2 diabetes
Once-weekly combination therapy of basal insulin icodec and semaglutide was noninferior to insulin glargine plus insulin aspart for lowering HbA1c among adults with type 2 diabetes, according to topline results from a phase 3a trial.
Time-restricted eating reduces weight, HbA1c for adults with type 2 diabetes
Adults with type 2 diabetes and obesity achieved greater weight loss with time-restricted eating at 6 months than with calorie restriction or continuing usual eating habits, according to study data.
Protection from nirsevimab may last longer than an RSV season
Nirsevimab, a monoclonal antibody recently approved to prevent respiratory syncytial virus-associated lower respiratory disease in newborns and infants, may protect longer than an RSV season, researchers reported at IDWeek.
Metformin provides glycemic, neonatal benefits for women with gestational diabetes
Metformin may lengthen the time until insulin initiation, lower fasting glucose and improve neonatal outcomes for pregnant women with gestational diabetes, according to data from a randomized trial.